Pediatric Kidney Disease (Nephrology)

On this page
Lifesaving care for children with kidney disease
At UCSF Benioff Children's Hospitals, we offer comprehensive care for infants, children and teens with kidney and urinary tract conditions, ranging from kidney stones to chronic kidney disease (CKD). You can find the care you need for your child's needs, whether it's a routine concern or a condition requiring more specialized care.
Our pediatric nephrology program is one of the largest in Northern California and consistently ranked among the best in the nation. We provide the latest kidney disease treatments with a family-centered, kid-friendly approach. With locations across the Bay Area, it's easy for families to access high-quality kidney care.
Our collaborative approach to pediatric nephrology
Our program brings together a team of pediatric experts to support your child's kidney health, including:
Nephrologists
Kidney transplant surgeons
Urologists
Nutritionists
Social workers
Our pediatric nephrologists are highly skilled in caring for children with acute kidney failure (sudden loss of kidney function) and end-stage renal disease (ESRD). We have a state-of-the-art pediatric dialysis center, one of the few centers in Northern California offering dialysis services exclusively for kids.
We are also home to one of the oldest and most successful kidney transplant programs in the U.S. Through our expertise and experience, we offer children with the most serious illnesses the greatest chance to live healthier lives.
Lifesaving care for children with kidney disease
At UCSF Benioff Children's Hospitals, we offer comprehensive care for infants, children and teens with kidney and urinary tract conditions, ranging from kidney stones to chronic kidney disease (CKD). You can find the care you need for your child's needs, whether it's a routine concern or a condition requiring more specialized care.
Our pediatric nephrology program is one of the largest in Northern California and consistently ranked among the best in the nation. We provide the latest kidney disease treatments with a family-centered, kid-friendly approach. With locations across the Bay Area, it's easy for families to access high-quality kidney care.
Our collaborative approach to pediatric nephrology
Our program brings together a team of pediatric experts to support your child's kidney health, including:
Nephrologists
Kidney transplant surgeons
Urologists
Nutritionists
Social workers
Our pediatric nephrologists are highly skilled in caring for children with acute kidney failure (sudden loss of kidney function) and end-stage renal disease (ESRD). We have a state-of-the-art pediatric dialysis center, one of the few centers in Northern California offering dialysis services exclusively for kids.
We are also home to one of the oldest and most successful kidney transplant programs in the U.S. Through our expertise and experience, we offer children with the most serious illnesses the greatest chance to live healthier lives.
Locations (dynamic)
Providers (dynamic)

Paul R. Brakeman, MD
Nephrology • Pediatric Nephrology
Rim El Chaki, MD
Pediatrics • Pediatric Nephrology
Jason Lee, MD
Pediatrics • Pediatric Nephrology
Marsha Lee, MD
Nephrology • Pediatric Nephrology
Awards & achievements
Related conditions & treatments
Conditions
- Acute Kidney Injury
- Chronic Kidney Disease (CKD)
- Electrolyte Disorders
- End Stage Renal Disease
- Hydronephrosis
- Kidney Disease
- Kidney Stone
- Nephritis
- Renal Hypertension
Treatments
- Dialysis
- Kidney Surgery
- Kidney Transplant
- Living Donor Kidney Transplant
Clinical trials
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)Opens in a new window
This study is open to children aged 2 to 17 with chronic kidney disease (CKD). The purpose of this study is to find out if a medicine called empagliflozin helps children and adolescents with CKD. Other goals of the study are to find out how empagliflozin is tolerated and handled by the body in children and adolescents with CKD. Participants are put into 2 groups randomly, which means by chance...Ferric Citrate and Chronic Kidney Disease in ChildrenOpens in a new window
We will conduct a 12-month, double-blind, randomized, placebo-controlled trial to assess the effects of therapy with ferric citrate (FC) on changes in intact FGF23 levels (iFGF23, primary endpoint) in 160 pediatric patients (80 in each of the two arms) aged 6-18 years of either sex with chronic kidney disease (CKD) stages 3-4 and age-appropriate normal serum phosphate levels...Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney DiseaseOpens in a new window
The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney disease.


















